4Retsky KL, Freeman MW, Frei B. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti - rather than prooxidant activity of vitamin C in the presence of transition metal ions [J]. J Biol Chem, 1993,
5Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases[J]. Ann Rev Pharmacol Toxicol, 1996, 36:83 -106.
6Kontush A, Weber W, Beisiegel U. Alpha - and beta - carotene in low density lipoprotein are the preferred targets for nitric oxide - induced oxidation [J]. Atherosclerosis, 2000, 148: 87.
7Clarris HJ, Key B, Beyreuther K et al. Expression of the amyloid protein precursor of Alzheimer's disease in the developing rat olfactory system [J] , Brain Res Dev Brain Res, 1995, 88 (1): 87 -95.
8Sano M, Emesto C, Thomas RG, et al. A controlled trial of selegiline, alpha- ocopherol, or both as treatment for Alzheimer's disease[J]. N EnglJMed, 1997, 336 (17): 1216 -1222.
9Luchsinger JA, Tang MX, Shea S, Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease [ J ]. Archives of Neurology,2003, 60 (2): 203.
10Arlt S, Kontush A, Muller - Thomsen, et al. Lipoproteinoxidation as a common pathomechanism in coronary heart disease and Alzheimer disease [J]. Zeitschrift fur Gerontologie and Geriatrie, 2001, 34 (6):461.
